Sarcoidosis and tuberculosis: A connection to the human leukocyte antigen system

Advances in Experimental Medicine and Biology

Volumn 756, Issue , 2013, Pages 229-237

  Dubaniewicz, A ^a   Zimmermann, A ^a   Smigielska, M ^a   Dubaniewicz Wybieralska, M ^a   Moszkowska, G ^a   Wysocka, J ^a   Adamczyk Bak, K ^a   Slominski, J M ^a   Deeg, P ^a,b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Autoimmunity; Ethnicity; Genetic factors; Human leukocyte antigens system; Sarcoidosis; Tuberculosis

Indexed keywords

GENOMIC DNA; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; PREDNISONE; STEROID; TUBERCULOSTATIC AGENT;

ADULT; ALLELE; BACTERIUM CULTURE; CASE REPORT; CD4 CD8 RATIO; CONFERENCE PAPER; COUGHING; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ENVIRONMENTAL FACTOR; ERYTHEMA NODOSUM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIGH RISK PATIENT; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFECTION RISK; LUNG AUSCULTATION; LUNG BIOPSY; LUNG INFILTRATE; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MEDIASTINOSCOPY; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; REMISSION; RISK ASSESSMENT; RISK FACTOR; STEROID THERAPY; THORAX RADIOGRAPHY; TREND STUDY; TUBERCULOSIS;

EID: 84867489049     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4549-0_29     Document Type: Conference Paper

References (28)

1. American Thoracic Society. (1999). Statement on sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 160 , 736-755.
2. Dubaniewicz, A. (2010). Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmunity Reviews, 9 (6), 419-424.
3. Dubaniewicz, A., & Dubaniewicz, A. (2005). Human Leukocyte antigens class I and class II: Associations and distribution in different ethnic groups of patients with pulmonary tuberculosis. Current Respiratory Medicine Reviews, 1 (2), 117-121.
4. Dubaniewicz, A., Szczerkowska, Z., & Hoppe, A. (2003). Comparative analysis of HLA class I antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group. Mayo Clinic Proceedings, 78 (4), 436-442.
5. Dubaniewicz, A., Moszkowska, G., & Szczerkowska, Z. (2005). Frequency of DRB1-DQB1 two-locus haplotypes in tuberculosis: Preliminary report. Tuberculosis (Edinburgh, Scotland), 85 , 259-267.
6. Dubaniewicz, A., Dubaniewicz-Wybieralska, M., Moszkowska, G., Sternau, A., & Dubaniewicz, A. (2006). Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: Preliminary study. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 23 (3), 180-189.
7. Goljan, A., Puscinska, E., Sankowska, M., & Zielinski, J. (2000). Polymorphism of histocompatibility class II antigens coded with the DRB gene in familial sarcoidosis in Poland. Pneumonologia i Alergologia Polska, 68 (11-12), 533-544.
8. Grosser, M., Luther, T., Fuessel, M., Bickhardt, J., Magdolen, V., & Baretton, G. (2005). Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, in fl ammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis, Vasculitis, and Lung Diseases, 22 (1), 66-74.
9. Idali, F., Wiken, M., Wahlstrom, J., Mellstedt, H., Eklund, A., Rabbani, H., & Grunewald, J. (2006). Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. European Respiratory Journal, 27 (3), 451-459.
10. Khomenko, A. G., Litvinova, V. I., Chukanovaa, V. P., & Pospelova, L. E. (1990). Tuberculosis in patients with various HLA phenotypes. Tubercle, 71 (3), 187-192.
11. Kurian, S. M., Selvaraj, P., Reetha, A. M., Charles, N., & Narayanan, P. R. (2004). HLA-DR phenotypes and lymphocyte response to M. tuberculosis antigens in cures spinal tuberculosis patients and their contacts. The Indian Journal of Tuberculosis, 51 , 71-75.
12. Livnat, S., Madden, K. S., Felten, D. L., & Felten, S. Y. (1987). Regulation of the immune system by sympathetic neural mechanisms. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 11 (2-3), 145-152.
13. Mach, F. (2002). Immunosuppressive effects of statins. Atherosclerosis Supplements, 3 (1), 17-20.
14. Messerli, F. H., & Grossman, E. (1998). The calcium antagonist controversy: A posthumous commentary. The American Journal of Cardiology, 82 (9B), 35R-39R.
15. Moller, D. R. (2007). Potential etiologic agents in sarcoidosis. Proceedings of the American Thoracic Society, 4 (5), 465-468.
16. Morgenthau, A. S., & Iannuzzi, M. C. (2011). Recent advances in sarcoidosis. Chest, 139 (1), 174-182.
17. Mrazek, F., Holla, L. I., Hutyrova, B., Znojil, V., Vasku, A., Kolek, V., Welsh, K. I., Vacha, J., du Bois, R. M., & Petrek, M. (2005). Association of tumor necrosis factor-a , lymphotoxin-a and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens, 65 (2), 163-171.
18. Olerup, O., & Zetterquist, H. (1991). HLA-DRB1*01 subtyping by allele-speci fi c PCR ampli fi cation: A sensitive, speci fi c and rapid technique. Tissue Antigens, 37 (5), 197-204.
19. Papadopoulos, K. I., Wassmuth, R., Sponsel, T., Sjöberg, K., & Hallengren, B. (2006). Sarcoidosis and autoimmunity: Evidence of differential associations with HLA class II markers. International Journal of Endocrinology and Metabolism, 4 , 13-18.
20. Plesner, A., Greenbaum, C. J., Gaur, L. K., Ernst, R. K., & Lernmark, A. (2002). Macrophages from high-risk HLADQB1*0201/*0302 type 1 diabetes mellitus patients are hypersensitive to lipopolysacharide stimulation. Scandinavian Journal of Immunology, 56 (5), 522-529.
21. Price, P., Witt, C., Allcock, R., Sayer, D., Garlepp, M., Kok, C. C., French, M., Mallal, S., & Christiansen, F. (1999). The genetic basis for the association of the 8.1 ancestral haplotype (A1,B8,DR3) with multiple immunopathological diseases. Immunology Reviews, 167 , 257-274.
22. Sato, H., Woodhead, F. A., Ahmad, T., Grutters, J. C., Spagnolo, P., van den Bosch, J. M., Maier, L. A., Newman, L. S., Nagai, S., Izumi, T., Wells, A. U., du Bois, R. M., & Welsh, K. I. (2010). Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Human Molecular Genetics, 19 (20), 4100-4111.
23. Sidney, J., del Guercio, M. F., Southwood, S., & Sette, A. (2002). The HLA molecules DQA1*0501/B1*0201 and DQA1*0301/ B1*0302 share an extensive overlap in peptide binding speci fi city. Journal of Immunology, 169 (9), 5098-5108.
24. Steffens, S., & Mach, F. (2004). Anti-in fl ammatory properties of statins. Seminars in Vascular Medicine, 4 (4), 417-422.
25. Swider, C., Schnittger, L., Bogunia-Kubik, K., Gerdes, J., Flad, H.-D., Lange, A., & Seitze, U. (1999). TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. European Cytokine Network, 10 (2), 143-146.
26. Wahlstrom, J., Katchar, K., Wigzell, H., Olerup, O., Eklund, A., & Grunewald, J. (2001). Analysis of intracellular cytokines in CD4 + and CD8 + lung and blood T cells in sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 163 (1), 115-121.
27. Walzl, G., Ronacher, K., Hanekom, W., Scriba, T. J., & Zumla, A. (2011). Immunological biomarkers of tuberculosis. Nature Reviews Immunology, 11 (5), 343-354.
28. Yim, J. J., & Selvaraj, P. (2010). Genetic susceptibility in tuberculosis. Respirology, 15 (2), 241-256.